Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma.

P A Godley1, K I Ataga

  • 1University of North Carolina at Chapel Hill, Division of Hematology/Oncology and the Lineberger Comprehensive Cancer Center, Chapel Hill 27599-7305, USA. pgodley@med.unc.edu

Current Opinion in Oncology
|June 7, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.

Journal of thrombosis and haemostasis : JTH·2016
Same author

The contribution of red blood cells to thrombin generation in sickle cell disease: meizothrombin generation on sickled red blood cells.

Journal of thrombosis and haemostasis : JTH·2013
Same author

The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for African American men: the North Carolina-Louisiana Prostate Cancer Project.

Journal of the National Medical Association·2013
Same author

Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2013
Same author

Patient Satisfaction Influenced by interpersonal treatment and communication for African American men: the North Carolina-Louisiana Prostate Cancer Project (PCaP).

American journal of men's health·2012
Same author

Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial.

JAMA·2001
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Renal cell carcinoma incidence is rising, linked to factors like hypertension and diet. Early detection and treatments like partial nephrectomy and immunotherapy offer improved survival outcomes.

Area of Science:

  • Oncology
  • Urology

Background:

  • Rising incidence of renal cell carcinoma (RCC) with unclear causes beyond increased imaging.
  • Identified risk factors include hypertension, smoking, obesity, and dietary patterns.
  • Carotene intake shows an inverse association with RCC risk, while red meat intake correlates with increased risk.

Purpose of the Study:

  • To review current understanding of renal cell carcinoma incidence, risk factors, and treatment modalities.
  • To highlight prognostic indicators for patient survival.
  • To discuss emerging therapeutic strategies and their efficacy.

Main Methods:

  • Literature review of epidemiological data and clinical studies on renal cell carcinoma.
  • Analysis of risk factors, including lifestyle and genetic predispositions.

Related Experiment Videos

  • Evaluation of treatment outcomes for localized disease, metastatic disease, and systemic therapy.

    • Main Results:

    • Partial nephrectomy shows comparable effectiveness to radical nephrectomy for localized RCC.
    • Radiosurgery is a viable alternative to surgical resection for brain metastases.
    • Immunotherapy demonstrates response rates of 5-20% in systemic treatment.

    Conclusions:

    • Survival in renal cell carcinoma is influenced by pathologic stage, grade, vascular invasion, and specific genetic alterations.
    • Prognosis is worsened by genetic factors such as deletion (8p)/-8, +12, and +20.
    • Continued research into risk factors and treatment optimization is crucial for improving patient outcomes.